Free Float -
Shares Float -
Shares Outstanding 23,12 M
Peak Bio, Inc. Share · US70470P1084 · PKBO (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Peak Bio, Inc.
No Price
Share Float & Liquidity
Company Profile for Peak Bio, Inc. Share
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.
Company Data
Name Peak Bio, Inc.
Company Peak Bio, Inc.
Symbol PKBO
Website
https://peak-bio.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US70470P1084
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Hoyoung Huh
Country United States of America
Currency USD
Employees 0,0 T
Address 3350 W Bayshore Rd., 94303 Palo Alto
IPO Date 2022-11-02
ID Changes
| Date | From | To |
|---|---|---|
| 02.11.2022 | IGNY | PKBO |
| 02.11.2022 | IGNYW | PKBOW |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | PKBOW |
| NASDAQ | PKBO |
More Shares
Investors who hold Peak Bio, Inc. also have the following shares in their portfolio:
